BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33403946)

  • 1.
    Mitra D; Pandey J; Jain A; Swaroop S
    J Biomol Struct Dyn; 2022 Jul; 40(11):5189-5202. PubMed ID: 33403946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
    Yang Z; Bogdan P; Nazarian S
    Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple epitope-based vaccine prediction against SARS-CoV-2 spike glycoprotein.
    Sirohi PR; Gupta J; Somvanshi P; Prajapati VK; Grover A
    J Biomol Struct Dyn; 2022 May; 40(8):3347-3358. PubMed ID: 33246394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-epitope vaccine against SARS-CoV-2 applying immunoinformatics and molecular dynamics simulation approaches.
    Jyotisha ; Singh S; Qureshi IA
    J Biomol Struct Dyn; 2022 Apr; 40(7):2917-2933. PubMed ID: 33164664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus.
    Singh J; Malik D; Raina A
    Vaccine; 2021 Feb; 39(7):1087-1095. PubMed ID: 33478787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A vaccine built from potential immunogenic pieces derived from the SARS-CoV-2 spike glycoprotein: A computational approximation.
    Marchan J
    J Immunol Methods; 2022 Mar; 502():113216. PubMed ID: 35007561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of multi-epitope vaccine candidate against SARS-CoV-2: a
    Abraham Peele K; Srihansa T; Krupanidhi S; Ayyagari VS; Venkateswarulu TC
    J Biomol Struct Dyn; 2021 Jul; 39(10):3793-3801. PubMed ID: 32419646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein.
    Chukwudozie OS; Gray CM; Fagbayi TA; Chukwuanukwu RC; Oyebanji VO; Bankole TT; Adewole RA; Daniel EM
    PLoS One; 2021; 16(3):e0248061. PubMed ID: 33730022
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Devi A; Chaitanya NSN
    J Biomol Struct Dyn; 2021 Nov; 39(18):6903-6917. PubMed ID: 32772892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An
    Dar HA; Waheed Y; Najmi MH; Ismail S; Hetta HF; Ali A; Muhammad K
    J Immunol Res; 2020; 2020():8893483. PubMed ID: 33274246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch vaccines, designed by reverse epitomics approach, show potential to cover large ethnically distributed human population worldwide.
    Srivastava S; Verma S; Kamthania M; Agarwal D; Saxena AK; Kolbe M; Singh S; Kotnis A; Rathi B; Nayar SA; Shin HJ; Vashisht K; Pandey KC
    J Biomol Struct Dyn; 2022 Mar; 40(5):2369-2388. PubMed ID: 33155524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole proteome screening and identification of potential epitopes of SARS-CoV-2 for vaccine design-an immunoinformatic, molecular docking and molecular dynamics simulation accelerated robust strategy.
    Ezaj MMA; Junaid M; Akter Y; Nahrin A; Siddika A; Afrose SS; Nayeem SMA; Haque MS; Moni MA; Hosen SMZ
    J Biomol Struct Dyn; 2022 Sep; 40(14):6477-6502. PubMed ID: 33586620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant.
    Khan K; Khan SA; Jalal K; Ul-Haq Z; Uddin R
    Virology; 2022 Jul; 572():28-43. PubMed ID: 35576833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A conserved subunit vaccine designed against SARS-CoV-2 variants showed evidence in neutralizing the virus.
    Kibria KMK; Faruque MO; Islam MSB; Ullah H; Mahmud S; Miah M; Saleh AA
    Appl Microbiol Biotechnol; 2022 Jun; 106(11):4091-4114. PubMed ID: 35612630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach.
    Samad A; Ahammad F; Nain Z; Alam R; Imon RR; Hasan M; Rahman MS
    J Biomol Struct Dyn; 2022 Jan; 40(1):14-30. PubMed ID: 32677533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoinformatics study to search epitopes of spike glycoprotein from SARS-CoV-2 as potential vaccine.
    Lizbeth RG; Jazmín GM; José CB; Marlet MA
    J Biomol Struct Dyn; 2021 Aug; 39(13):4878-4892. PubMed ID: 32583729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coevolution based immunoinformatics approach considering variability of epitopes to combat different strains: A case study using spike protein of SARS-CoV-2.
    Mishra SK; Priya P; Rai GP; Haque R; Shanker A
    Comput Biol Med; 2023 Sep; 163():107233. PubMed ID: 37422941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rational design of a multi-epitope vaccine against SARS-CoV-2 which accounts for the glycan shield of the spike glycoprotein.
    Martin WR; Cheng F
    J Biomol Struct Dyn; 2022 Sep; 40(15):7099-7113. PubMed ID: 33715598
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Susithra Priyadarshni M; Isaac Kirubakaran S; Harish MC
    J Biomol Struct Dyn; 2022; 40(23):12948-12963. PubMed ID: 34528491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunodominant linear B cell epitopes in the spike and membrane proteins of SARS-CoV-2 identified by immunoinformatics prediction and immunoassay.
    Polyiam K; Phoolcharoen W; Butkhot N; Srisaowakarn C; Thitithanyanont A; Auewarakul P; Hoonsuwan T; Ruengjitchatchawalya M; Mekvichitsaeng P; Roshorm YM
    Sci Rep; 2021 Oct; 11(1):20383. PubMed ID: 34650130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.